Tackling Antimicrobial Resistance in Developing Countries: The Role of Aid and International Agencies

Antimicrobial resistance (AMR) threatens future growth and prosperity, as well as health. Without global action, the UK's Review on Antimicrobial Resistance, led by Lord Jim O'Neill, estimates that an additional 10 million people will die every year from drug-resistant infections and the global economy will experience a loss of $100 trillion by 2050. The impact from rising drug resistance will be felt worldwide, hitting low- and middle-income countries hardest.

More Reading

Event

Are Health Benefits Packages Delivering on Their Promise?

VIRTUAL
November 12, 2026
12:30—2:00 PM GMT | 7:30—9:00 AM EST
The gloved hand of a medical technician or researcher in search for a vaccine for COVID19 uses a syringe to extract from a vial labeled for clinical trial use.
Blog Post

AI is Moving Faster Than Clinical Trials. Here’s How We Can Catch Up.

Anthony McDonnell
October 15, 2026
Hands of medical operator conducting a fingerprick blood test
Blog Post

The Case for Scaling Fingerprick Blood Lead Testing

Siddhartha Haria et al.
October 12, 2026
Clinical trial medicine, for the covid-19 coronavirus, on clipboard
WORKING PAPER

Learning at the Speed of AI: Using Platform Trials to Test AI Innovation

Anthony McDonnell
October 15, 2026